SODIUM 9-(((2E)-4-((2R,3AS,6S,7S,7AR)-2-((1S,2S,3S)-1,3-DIHYDROXY-2-METHYLBUTYL)-7-HYDROXY-HEXAHYDRO-2H-FURO(3,2-C)PYRAN-6-YL)-3-METHYLBUT-2-ENOYL)OXY)NONANOATE
UNII PK98CF4MMT
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 9-(((2e)-4-((2r,3as,6s,7s,7ar)-2-((1s,2s,3s)-1,3-dihydroxy-2-methylbutyl)-7-hydroxy-hexahydro-2h-furo(3,2-c)pyran-6-yl)-3-methylbut-2-enoyl)oxy)nonanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PK98CF4MMT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 116182-43-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H43O9.Na WGWNMOGICRTCLI-QKSOIFRQSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 9-(((2e)-4-((2r,3as,6s,7s,7ar)-2-((1s,2s,3s)-1,3-dihydroxy-2-methylbutyl)-7-hydroxy-hexahydro-2h-furo(3,2-c)pyran-6-yl)-3-methylbut-2-enoyl)oxy)nonanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.